Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?
Curr Hematol Malig Rep
.
2017 Dec;12(6):507-509.
doi: 10.1007/s11899-017-0423-9.
Authors
Brady L Stein
1
2
,
Srdan Verstovsek
3
Affiliations
1
Division of Hematology-Oncology, Department of Medicine, Chicago, IL, 60611, USA. Brady.Stein@nm.org.
2
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, 60611, USA. Brady.Stein@nm.org.
3
Leukemia Department, MD Anderson Cancer Center, Houston, TX, 77030, USA.
PMID:
29032412
DOI:
10.1007/s11899-017-0423-9
No abstract available
Keywords:
Myeloproliferative neoplasm; Polycythemia vera; Prognosis.
Publication types
Review
MeSH terms
Humans
Polycythemia Vera / mortality
Polycythemia Vera / pathology
Polycythemia Vera / therapy*
Prognosis
Survival Rate